Immune Checkpoint Inhibition in Non-Melanoma Skin Cancer: A Review of Current Evidence

Overview of attention for article published in Frontiers in oncology, December 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (60th percentile)

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 7,743 followers.

Frontiers | Immune Checkpoint Inhibition in Non-Melanoma Skin Cancer: A Review of Current Evidence | Oncology https://t.co/7v2tKGcF0S

📄 Immune Checkpoint Inhibition in Non-Melanoma Skin Cancer: A Review of Current Evidence 👨‍⚕️👩‍⚕️ Connor J. Stonesifer et al Read here 👉 https://t.co/sBGfVbavRd @Rdcarval #SkinCancerAwarnessMonth #Immunotherapy

New article: Immune Checkpoint Inhibition in Non-Melanoma Skin Cancer: A Review of Current Evidence https://t.co/ZHp0HZuILy #melanoma #oncology https://t.co/RdlrjMwzFN

⭐ This weeks top 5 articles ⭐ #3: Immune Checkpoint Inhibition in Non-Melanoma #SkinCancer: A Review of Current Evidence 👩‍⚕️👨‍⚕️ Connor J. Stonesifer, A. Reza Djavid et al. Read now 👉 https://t.co/eN7wn6e263 @ColumbiaPS @ColumbiaMed #SKsm #ImmunoOnc #

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.